Delivery Order SPE2DB22D1202-SPE2DB24FUZN0

Award Date 5/6/24
Potential Completion Date 5/7/24
Potential Value $1.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order (SPE2DB24FJV47) awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of Diprivan 1,000 mg/100 ml vials. The award has a ceiling value of $3,733.09 and an ultimate completion date of August 19, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued at up to $999,999,999 and $750,000 respectively, for providing a wide range...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,141.98 firm fixed price contract is for the supply of DIPRIVAN 500 MG/50 ML VIAL 50ML, a critical pharmaceutical product. The award has an ultimate completion date of May 28, 2024. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the U.S. federal government, including military treatment facilities and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division. The contract has a ceiling value of $4,097.46 and is for the delivery of DIPRIVAN 1,000 MG/100 ML VIAL 100ML, a critical pharmaceutical product. The contract is a firm-fixed price instrument with an ultimate completion date of August 26, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this delivery order as part of its Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,709.70 firm fixed-price delivery order is for the supply of 4,560,521,815 units of the drug Diprivan (1,000 mg/100 ml vial, 100 ml) with an ultimate completion date of April 10, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The $4,647.84 firm fixed price contract is for the delivery of DIPRIVAN 1,000 MG/100 ML VIAL 100ML, with a period of performance through July 2, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to...
This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for 4,564,388 units of the pharmaceutical product Diprivan, a 1,000 mg/100 ml vial, at a ceiling value of $2,637.34. The order was awarded on a firm fixed price basis without any set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $1,350.52 Firm Fixed Price delivery order is for the supply of 1,000 mg/100 ml vials of the pharmaceutical product Diprivan. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by AmerisourceBergen with the DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the procurement of DIPRIVAN 500 MG/50 ML VIAL 50ML. The contract is a Delivery Order valued at $2,108.29 with a Firm Fixed Price pricing type. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. Cencora,...
This is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order, valued at $1,220.68, is for the supply of DIPRIVAN 200 MG/20 ML VIAL 20ML, a pharmaceutical product. The delivery order was issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value of up to $999,999,999.00 and a performance period through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of DIPRIVAN 200 MG/20 ML VIAL 20ML. The contract has a ceiling value of $2,562.65 and an ultimate completion date of November 8, 2022. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FUZN0
    Delivery Order

This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation. The contract is for the supply of Diprivan 200 mg/20 ml vial, a pharmaceutical product, with a ceiling value of $1,303.02 and a performance period ending on May 7, 2024.

Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation for the provision of a wide range of pharmaceutical products and medical supplies to support various government healthcare programs. This specific contract award does not have a set-aside designation, indicating it was competed on a full and open basis. As the parent company of Amerisourcebergen Drug Corp, Cencora, Inc. is also listed as a party to this contract.

Generated 8/5/24, 9:20 AM